JPWO2021079887A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021079887A5
JPWO2021079887A5 JP2021553473A JP2021553473A JPWO2021079887A5 JP WO2021079887 A5 JPWO2021079887 A5 JP WO2021079887A5 JP 2021553473 A JP2021553473 A JP 2021553473A JP 2021553473 A JP2021553473 A JP 2021553473A JP WO2021079887 A5 JPWO2021079887 A5 JP WO2021079887A5
Authority
JP
Japan
Prior art keywords
substituted
cycloalkyl
alkyl
heteroalkyl
cycloheteroalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021553473A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021079887A1 (https=
JP7649999B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2020/039450 external-priority patent/WO2021079887A1/ja
Publication of JPWO2021079887A1 publication Critical patent/JPWO2021079887A1/ja
Publication of JPWO2021079887A5 publication Critical patent/JPWO2021079887A5/ja
Application granted granted Critical
Publication of JP7649999B2 publication Critical patent/JP7649999B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021553473A 2019-10-25 2020-10-20 タウオパチーの予防又は治療剤 Active JP7649999B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019194758 2019-10-25
JP2019194758 2019-10-25
PCT/JP2020/039450 WO2021079887A1 (ja) 2019-10-25 2020-10-20 タウオパチーの予防又は治療剤

Publications (3)

Publication Number Publication Date
JPWO2021079887A1 JPWO2021079887A1 (https=) 2021-04-29
JPWO2021079887A5 true JPWO2021079887A5 (https=) 2023-11-17
JP7649999B2 JP7649999B2 (ja) 2025-03-24

Family

ID=75620677

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021553473A Active JP7649999B2 (ja) 2019-10-25 2020-10-20 タウオパチーの予防又は治療剤

Country Status (7)

Country Link
US (1) US20220296548A1 (https=)
EP (1) EP4049679A4 (https=)
JP (1) JP7649999B2 (https=)
CN (1) CN114599397B (https=)
AU (1) AU2020370758B2 (https=)
CA (1) CA3159067A1 (https=)
WO (1) WO2021079887A1 (https=)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5084479A (en) * 1990-01-02 1992-01-28 Warner-Lambert Company Novel methods for treating neurodegenerative diseases
CA2327285C (en) 1998-05-15 2005-06-14 Warner-Lambert Company Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
US20020103360A1 (en) 1998-09-01 2002-08-01 Yang Pan Novel protein related to melanoma-inhibiting protein and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
AR061728A1 (es) * 2006-06-30 2008-09-17 Pfizer Prod Inc Composicion para tratamiento usando compuestos selectivos alfa-2-delta-1
EP2018854A1 (en) * 2007-07-27 2009-01-28 Merz Pharma GmbH & Co. KGaA Novel combinations of neramexane for the treatment of neurodegenerative disorders
WO2009029173A1 (en) * 2007-08-23 2009-03-05 The Board Of Trustees Of The Leland Stanford Junior University Modulation of synaptogenesis
EP2657219B1 (en) 2007-09-28 2014-12-10 Daiichi Sankyo Company, Limited Intermediate for producing bicyclic y-amino acid derivative
US20110287014A1 (en) * 2008-11-24 2011-11-24 Arnon Rosenthal Antibodies directed against calcium channel subunit alpha2/delta and methods using same
AU2010286501B2 (en) 2009-08-28 2015-06-11 The Board Of Regents Of The University Of Texas System Antibodies that bind Tau oligomers
KR20170085792A (ko) * 2016-01-15 2017-07-25 서울대학교산학협력단 Tsp-1을 포함하는 알츠하이머병 예방 또는 치료용 조성물
JP7162302B2 (ja) * 2016-10-07 2022-10-28 国立大学法人京都大学 Ftldの予防又は治療剤及びそのスクリーニング方法
JP2019194758A (ja) 2018-05-01 2019-11-07 キヤノン株式会社 情報処理装置、情報処理方法、およびプログラム

Similar Documents

Publication Publication Date Title
JP3207901B2 (ja) レトロウイルス阻害性化合物
JP2020512272A5 (https=)
JP2016535772A5 (https=)
JP2008528447A5 (https=)
JP2016537358A5 (https=)
US7531673B2 (en) Preparation of amino acid amides
JP2009519993A5 (https=)
JPWO2022145444A5 (https=)
JP2022529518A5 (https=)
JP2022525069A5 (https=)
JP2021512913A5 (https=)
CA2519956A1 (en) Compound
JP2009528318A5 (https=)
CN115867348A (zh) 作为il-17调节剂的咪唑并嘧啶
JP2006509842A5 (https=)
JP2025527291A5 (https=)
JPWO2021079887A5 (https=)
CS384691A3 (en) Retroviral protease inhibitors derived from3-chloro-2-chloromethyl-1-propane
CN103443084A (zh) 制备苯达莫司汀的方法
CA2580265A1 (en) Amino-containing compounds which inhibit memapsin 2 beta-secretase activity and methods of use thereof
JP3576193B2 (ja) ビフェニルメチル置換バレリルアミド誘導体
JP5929767B2 (ja) 窒素原子又は酸素原子を含む環構造を有する芳香族化合物の製造方法
TW201006811A (en) Preparation of protected alpha-keto beta-amino esters and amides
JP2008502672A5 (https=)
JPS6023363A (ja) N−(置換メチル)−アゼチジン−2−オン類